These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 30200715)

  • 41. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The Effect of p-JAK1/p-STAT3 Signaling Way in Intervening NAFLD by Blueberry Probiotic Serum].
    Zhu JJ; Cheng ML; Zhou MY; Zhao XK
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):203-209. PubMed ID: 28612527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats.
    Li M; Ye T; Wang XX; Li X; Qiang O; Yu T; Tang CW; Liu R
    PLoS One; 2016; 11(3):e0152085. PubMed ID: 27002331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Si-Ni-San inhibits hepatic Fasn expression and lipid accumulation in MAFLD mice through AMPK/p300/SREBP-1c axis.
    Lan T; Geng XJ; Zhang SJ; Zeng XX; Ying JJ; Xu Y; Liu SY; Li P; Tong YH; Wang W; Mao ZJ; Wang SW
    Phytomedicine; 2024 Jan; 123():155209. PubMed ID: 37984123
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPKα.
    Zhang M; Yuan Y; Wang Q; Li X; Men J; Lin M
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30291215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Influences and mechanisms of somatostatin on inflammation in endotoxin-induced acute lung injury mice].
    Xu L; Liu Y; Han W; Nan C; Li D; Hong G; Zhao G; Lu Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):315-20. PubMed ID: 24809259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study on the mechanism of Shenling Baizhu powder on the pathogenesis of pregnancy complicated with non-alcoholic fatty liver, based on PI3K/AKT/mTOR signal pathway.
    Le Y; Wang Z; Zhang Q; Miao L; Wang X; Han G
    Eur J Histochem; 2024 Sep; 68(3):. PubMed ID: 39287141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD).
    Araújo S; Soares E Silva A; Gomes F; Ribeiro E; Oliveira W; Oliveira A; Lima I; Lima MDC; Pitta I; Peixoto C
    Eur J Pharmacol; 2016 Oct; 788():306-314. PubMed ID: 27349145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3/AMPK/ACC Pathway.
    Zhang YP; Deng YJ; Tang KR; Chen RS; Liang S; Liang YJ; Han L; Jin L; Liang ZE; Chen YN; Yang QH
    Curr Med Sci; 2019 Feb; 39(1):37-43. PubMed ID: 30868489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism.
    Karimi-Sales E; Ebrahimi-Kalan A; Alipour MR
    Biomed Pharmacother; 2019 Jan; 109():1306-1312. PubMed ID: 30551380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Zhimu-Huangbai herb-pair ameliorates hepatic steatosis in mice by regulating IRE1α/XBP1s pathway to inhibit SREBP-1c.
    Zhao W; Wang X; Nie W; Jiang M; Zhao Y; Zhang T; Ding Y
    Phytomedicine; 2024 Nov; 134():156017. PubMed ID: 39265443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of Zuogui Jiangtang Qinggan Formula on lipid metabolism in db/db mouse model of type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease].
    Zhou M; Li L; Zou JJ; Liu X; Wu YJ; Xiang Q; Yu R
    Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(6):1587-1593. PubMed ID: 38621943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p/CPT1B axis.
    Dang Y; Xu J; Zhu M; Zhou W; Zhang L; Ji G
    Biomed Pharmacother; 2020 Jul; 127():110127. PubMed ID: 32325349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathway.
    Chen Q; Liu M; Yu H; Li J; Wang S; Zhang Y; Qiu F; Wang T
    J Nat Med; 2018 Jun; 72(3):655-666. PubMed ID: 29542003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats.
    Wang Y; Li JY; Han M; Wang WL; Li YZ
    Lipids Health Dis; 2015 Aug; 14():85. PubMed ID: 26242978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Asperuloside alleviates lipid accumulation and inflammation in HFD-induced NAFLD via AMPK signaling pathway and NLRP3 inflammasome.
    Shen Q; Chen Y; Shi J; Pei C; Chen S; Huang S; Li W; Shi X; Liang J; Hou S
    Eur J Pharmacol; 2023 Mar; 942():175504. PubMed ID: 36641101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Regulatory effect of Di'ao Xinxuekang on TLR4/MyD88/NF-κB signaling pathway in atherosclerotic rats].
    Zhang WZ; Li GY; Qi Q; Na S; Lyu L; Chen GL
    Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):602-608. PubMed ID: 32237519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibitory effects of saikosaponin-d on CCl4-induced hepatic fibrogenesis in rats.
    Dang SS; Wang BF; Cheng YA; Song P; Liu ZG; Li ZF
    World J Gastroenterol; 2007 Jan; 13(4):557-63. PubMed ID: 17278221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway.
    Fan L; Niu H; Zhao L; Yao R; He X; Lu B; Pang Z
    Biomed Pharmacother; 2022 Apr; 148():112697. PubMed ID: 35176709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of Eletroacupuncture Intervention on Insulin Resistance, Lipid Metabolic Disorder and Expression of Hepatic SREBP-1 c and Fatty Acid Synthase Proteins in Rats with Hyperlipidemia].
    Li ZX; Zhang HH; Lan DC; Zhang HT; Chen XZ; Sun J
    Zhen Ci Yan Jiu; 2018 Jan; 43(1):8-13. PubMed ID: 29383887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.